| scholarly article | Q13442814 |
| P50 | author | Joacim Rocklöv | Q37366758 |
| Solbritt Rantapää Dahlqvist | Q43197602 | ||
| Johan Rönnelid | Q90355980 | ||
| P2093 | author name string | Heidi Kokkonen | |
| Lisbeth Ärlestig | |||
| Mohammed Mullazehi | |||
| P2860 | cites work | Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 |
| A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis | Q24805387 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis | Q28267921 | ||
| The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
| Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins | Q31460983 | ||
| Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. | Q33953270 | ||
| Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. | Q34015846 | ||
| Twin concordance rates for rheumatoid arthritis: results from a nationwide study. | Q34357436 | ||
| Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis | Q34498921 | ||
| PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease | Q34896568 | ||
| Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations | Q35553712 | ||
| Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis | Q35620298 | ||
| Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles | Q35636886 | ||
| The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden | Q36392280 | ||
| Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets | Q37131055 | ||
| A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. | Q37480830 | ||
| Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated pr | Q42647972 | ||
| A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination | Q42676934 | ||
| Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis | Q44616885 | ||
| Gaining insight into PTPN22 and autoimmunity | Q46825387 | ||
| Microsatellite typing for DRB1 alleles: application to the analysis of HLA associations with rheumatoid arthritis | Q57330853 | ||
| Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease | Q58234911 | ||
| The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis | Q58234961 | ||
| Occurrence of rheumatoid arthritis in a nationwide series of twins | Q69757226 | ||
| Genome-wide meta-analysis for rheumatoid arthritis | Q83151084 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| antibody | Q79460 | ||
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 825-829 | |
| P577 | publication date | 2011-11-29 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden | |
| P478 | volume | 71 |
| Q38759315 | Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients |
| Q42715981 | Anti-citrullinated protein antibodies in rheumatoid arthritis: a bridge between genetic predisposition and autoimmunity |
| Q35121560 | Association of MASP-2 levels and MASP2 gene polymorphisms with rheumatoid arthritis in patients and their relatives. |
| Q50879987 | Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease. |
| Q37492376 | Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis |
| Q38220638 | Defining populations at risk of rheumatoid arthritis: the first steps to prevention |
| Q33805043 | Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis |
| Q43415346 | Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins |
| Q38388421 | Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses |
| Q92266513 | Genetic Risk for Rheumatoid Arthritis is Associated with Increased Striatal Volume in Healthy Young Adults |
| Q39298145 | Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis |
| Q36528908 | Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families. |
| Q39812962 | How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins |
| Q101409922 | Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies |
| Q90105320 | Increased IgA anti-citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients |
| Q90341768 | Individuals at risk of seropositive rheumatoid arthritis: the evolving story |
| Q34604615 | Insights from populations at risk for the future development of classified rheumatoid arthritis |
| Q36932166 | Is preclinical autoimmunity benign?: The case of cardiovascular disease |
| Q37228064 | Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study |
| Q37053019 | Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA) |
| Q27003201 | Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE |
| Q38712937 | Preclinical Rheumatoid Arthritis: Progress Toward Prevention |
| Q26863441 | Preclinical rheumatoid arthritis (autoantibodies): an updated review |
| Q41444983 | Prevalence of Anti-Citrullinated Protein Antibodies and IgM Rheumatoid Factor in First-Degree Relatives of Dutch Rheumatoid Arthritis Patients |
| Q92581618 | Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis |
| Q34349960 | Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis |
| Q90665705 | Secretory antibodies to citrullinated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives |
| Q35832816 | Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study |
| Q36366153 | Strategies to predict rheumatoid arthritis development in at-risk populations |
| Q35747705 | The lung may play a role in the pathogenesis of rheumatoid arthritis |
| Q40369679 | The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis |
| Q50308665 | The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis |
| Q33662199 | When and where does inflammation begin in rheumatoid arthritis? |
Search more.